Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACONW NASDAQ:AONC NASDAQ:DHACW NASDAQ:PMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACONWAclarion$0.04+3.4%$0.03$0.01▼$0.24N/AN/A31,852 shs278 shsAONCAmerican Oncology Network$11.15-0.3%$11.62$2.10▼$14.25N/AN/A2,971 shs7,265 shsDHACWDigital Health Acquisition$0.04$0.04$0.01▼$0.40N/AN/A71,147 shsN/APMDPsychemedics$2.67$2.52$1.63▼$3.25N/AN/AN/A113,627 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACONWAclarion0.00%-29.09%+18.98%+7.01%+15.84%AONCAmerican Oncology Network-2.78%+1.08%+9.07%+39.75%+205.46%DHACWDigital Health Acquisition0.00%+0.39%-53.62%-30.43%-56.90%PMDPsychemedics0.00%0.00%0.00%0.00%+17.11%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACONWAclarionN/AN/AN/AN/AN/AN/AN/AN/AAONCAmerican Oncology NetworkN/AN/AN/AN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APMDPsychemedicsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACONWAclarion 0.00N/AN/AN/AAONCAmerican Oncology Network 0.00N/AN/AN/ADHACWDigital Health Acquisition 0.00N/AN/AN/APMDPsychemedics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACONWAclarion$62.95KN/AN/AN/AN/AN/AAONCAmerican Oncology Network$1.34BN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/AN/APMDPsychemedics$19.68M0.83N/AN/A$0.84 per share3.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACONWAclarionN/AN/A0.00∞N/AN/AN/AN/AN/AAONCAmerican Oncology NetworkN/AN/A0.00∞N/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/APMDPsychemedics-$1.86M-$0.510.00∞N/A-9.26%-32.32%-18.53%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACONWAclarionN/AN/AN/AN/AN/AAONCAmerican Oncology NetworkN/AN/AN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/AN/AN/APMDPsychemedicsN/AN/AN/AN/A1 YearsCompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACONWAclarionN/AN/AN/AAONCAmerican Oncology NetworkN/AN/AN/ADHACWDigital Health AcquisitionN/AN/AN/APMDPsychemedics0.011.821.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACONWAclarionN/AAONCAmerican Oncology NetworkN/ADHACWDigital Health AcquisitionN/APMDPsychemedics32.07%Insider OwnershipCompanyInsider OwnershipACONWAclarionN/AAONCAmerican Oncology NetworkN/ADHACWDigital Health AcquisitionN/APMDPsychemedics13.96%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACONWAclarion7N/AN/ANot OptionableAONCAmerican Oncology Network1,520N/AN/ANot OptionableDHACWDigital Health AcquisitionN/AN/AN/ANot OptionablePMDPsychemedics1406.11 million5.26 millionNot OptionablePMD, ACONW, AONC, and DHACW HeadlinesRecent News About These CompaniesPsychemedics Releases 2025 Workforce Insights ReportJune 16, 2025 | globenewswire.comPsychemedics Named “Most Innovative Drug Testing Company of the Year”May 16, 2025 | globenewswire.comPsychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing InsightsMarch 3, 2025 | markets.businessinsider.comPhoenix Molecular Designs Launches Phase II Trial in RSK2-High Breast CancerFebruary 21, 2025 | precisionmedicineonline.comPInsider Buying: Psychemedics Co. (NASDAQ:PMD) Major Shareholder Acquires 60,000 Shares of StockDecember 18, 2024 | insidertrades.comPsychemedics Co. (NASDAQ:PMD) Major Shareholder Purchases $19,355.07 in StockDecember 13, 2024 | insidertrades.comInsider Buying: Psychemedics Co. (NASDAQ:PMD) Director Purchases 1,409,712 Shares of StockDecember 6, 2024 | insidertrades.comPsychemedics announces reverse stock split, forward stock splitDecember 3, 2024 | markets.businessinsider.comPsychemedics Corporation Announces Reverse and Forward Stock SplitDecember 2, 2024 | gurufocus.comPsychemedics Corporation Announces 1-for-5,000 Reverse Stock Split Followed by 5,000-for-1 Forward Stock SplitDecember 2, 2024 | quiverquant.comQPsychemedics Corporation Announces Reverse and Forward Stock SplitDecember 2, 2024 | globenewswire.comPsychemedics reminds stockholders to cast votes for Annual MeetingNovember 19, 2024 | markets.businessinsider.comPsychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of StockholdersNovember 18, 2024 | markets.businessinsider.comPsychemedics Reports Improved Losses Amid Revenue DipNovember 15, 2024 | markets.businessinsider.comPsychemedics Corporation Reports Third Quarter 2024 Financial ResultsNovember 12, 2024 | globenewswire.comPsychemedics Corporation (PMD)October 15, 2024 | finance.yahoo.comPsychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair TestingSeptember 26, 2024 | globenewswire.comPsychemedics Corporation Launches New Ketamine Hair Testing ServiceAugust 29, 2024 | finance.yahoo.comPsychemedics Corporation Reports Second Quarter 2024 Financial ResultsAugust 13, 2024 | globenewswire.comPsychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its ...August 12, 2024 | bakersfield.comBMedia Sentiment Over TimePMD, ACONW, AONC, and DHACW Company DescriptionsAclarion NASDAQ:ACONW$0.04 +0.00 (+3.42%) As of 03:25 PM EasternAclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.American Oncology Network NASDAQ:AONC$11.15 -0.03 (-0.27%) As of 03:44 PM EasternAmerican Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.Digital Health Acquisition NASDAQ:DHACW$0.04 0.00 (0.00%) As of 08/27/2025Digital Health Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.Psychemedics NASDAQ:PMDPsychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It NIO Just Got Its Second Upgrade of the Month, and It’s Big Chevron Stock Outlook: Dividend Growth Meets Inflation As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes Back Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access